You are here

Public Health

Paxlovid tied to fewer COVID-19 hospitalizations, reduced risk of long COVID --study

A new retrospective cohort study conducted in Dubai shows that the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, is tied to a 61% reduction in COVID-19 hospitalization and a 58% lower rate of long COVID.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Research into why protective antibodies fade after COVID-19 vaccines --NIH

  • Researchers found that current COVID-19 vaccines fail to generate mature and durable antibody-producing cells in the bone marrow.
  • The findings could help explain why protection tends to decline over time.
  • Better understanding of long-term immune responses could lead to improved vaccines that provide enduring protection.
  • ...
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Tuberculosis returns as top infectious disease killer--WHO

Tuberculosis returns as top infectious disease killer, WHO says

Oct 29 (Reuters) - Tuberculosis replaced COVID-19 to become the top cause for infectious disease-related deaths in 2023, according to a World Health Organization report published on Tuesday, highlighting the challenges in the global effort in eradicating the disease.
 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Public Health
howdy folks
Page loaded in 1.255 seconds.